Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance

Table 4

CD47 expression in normal endometrium, endometrial cancer, and endometrial hyperplasia.

Tissue type	Case	-	+	++	+++	Positive cases	Positive rate (%)	Strong positive cases	Strong positive rate (%)
Endometrial cancer	344	85	143	85	31	259	75.29	116	33.72
Endometrial hyperplasia	92	65	23	4	0	27	29.34	4	4.34
Simple hyperplasia	57	49	8	0	0	8	14.04	0	0
Complex hyperplasia	15	11	4	0	0	4	26.67	0	0
Atypical hyperplasia	20	5	11	4	0	15	75.00	4	20.00
Normal endometrium	118	89	29	0	0	29	24.58	0	0
Proliferative phase	83	66	17	0	0	17	20.48	0	0
Secretory phase	35	23	12	0	0	12	34.29	0	0

Note. weighed against endometrial hyperplasia group and normal endometrium group, ; weighed against the atypical hyperplasia group, .